Clinical Trial Update: Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study of oral PXD101 in patients with advanced solid tumors or lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• PXD101

Snippet

Sponsor: Valerio Therapeutics | Conditions: Solid Tumor, Lymphoma | Phase 1 | Status: COMPLETED